These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
292 related items for PubMed ID: 16998774
21. Distinguishing between primary infection and reinfection with rubella vaccine virus by IgG avidity assay in pregnant women. Hamkar R, Jalilvand S, Abdolbaghi MH, Jelyani KN, Esteghamati A, Hagh-goo A, Mohktari-Azad T, Nategh R. East Mediterr Health J; 2009; 15(1):94-103. PubMed ID: 19469431 [Abstract] [Full Text] [Related]
22. Efforts at rubella elimination in the United States: the impact of hemispheric rubella control. Dayan GH, Castillo-Solórzano C, Nava M, Hersh BS, Andrus J, Rodriguez R, Reef SE. Clin Infect Dis; 2006 Nov 01; 43 Suppl 3():S158-63. PubMed ID: 16998776 [Abstract] [Full Text] [Related]
23. Incidence of mumps and immunity to measles, mumps and rubella among US military recruits, 2000-2004. Eick AA, Hu Z, Wang Z, Nevin RL. Vaccine; 2008 Jan 24; 26(4):494-501. PubMed ID: 18155326 [Abstract] [Full Text] [Related]
24. Simulations of rubella vaccination strategies in China. Gao L, Hethcote H. Math Biosci; 2006 Aug 24; 202(2):371-85. PubMed ID: 16603207 [Abstract] [Full Text] [Related]
25. Waning antibodies in measles and rubella vaccinees--a longitudinal study. Kremer JR, Schneider F, Muller CP. Vaccine; 2006 Mar 24; 24(14):2594-601. PubMed ID: 16427163 [Abstract] [Full Text] [Related]
26. [The seroepidemiology of rubella in a female population of reproductive age in León, Guanajuato]. Macías-Hernández AE, Ponce de León S, Muñoz-Barrett JM, López-Jiménez F, Cano-Castro A, Vera-Peña A, Aguilar-Orozco G. Salud Publica Mex; 1993 Mar 24; 35(4):339-44. PubMed ID: 8342079 [Abstract] [Full Text] [Related]
27. [Pre and post-vaccinal rubella seroepidemiology in Brittany (1971-1975). Comparative study of Cendehill and Plotkin's strains]. Zou J, Senecal J, Morvan A, Roussey A. Ann Pediatr (Paris); 1976 Feb 02; 23(2):111-8. PubMed ID: 16104238 [No Abstract] [Full Text] [Related]
28. Prevalence of rubella antibodies among schoolgirls in Sana'a, Republic of Yemen. Sallam TA, Raja'a YA, Benbrake MS, Al-Shaibani KS, Al-Hababi AA. East Mediterr Health J; 2003 Feb 02; 9(1-2):148-51. PubMed ID: 15562744 [Abstract] [Full Text] [Related]
29. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Ovsyannikova IG, Jacobson RM, Vierkant RA, Jacobsen SJ, Pankratz VS, Poland GA. Hum Immunol; 2004 Dec 02; 65(12):1506-15. PubMed ID: 15603879 [Abstract] [Full Text] [Related]
30. Age specific rubella seroprevalence of an unvaccinated population of adolescents in Ankara, Turkey. Kanbur NO, Derman O, Kutluk T, Kinik E. Jpn J Infect Dis; 2003 Feb 02; 56(1):23-5. PubMed ID: 12711822 [Abstract] [Full Text] [Related]
31. Age-specific rubella seroprevalence in unvaccinated adolescents in Ankara, Turkey. Yalcin A, Caliskan D, Isik A. East Mediterr Health J; 2008 Feb 02; 14(5):1036-43. PubMed ID: 19161075 [Abstract] [Full Text] [Related]
32. Development of a rubella vaccination strategy: contribution of a rubella susceptibility study of women of childbearing age in Kyrgyzstan, 2001. Malakmadze N, Zimmerman LA, Uzicanin A, Shteinke L, Caceres VM, Kasymbekova K, Sozina I, Glasser JW, Joldubaeva M, Aidyralieva C, Icenogle JP, Strebel PM, Reef SE. Clin Infect Dis; 2004 Jun 15; 38(12):1780-3. PubMed ID: 15227627 [Abstract] [Full Text] [Related]
33. Rubella-antibodies in school children. LaBianca T, LaBianca J, Ibsen KK. Dan Med Bull; 1985 Oct 15; 32(5):267-9. PubMed ID: 4053697 [Abstract] [Full Text] [Related]
34. Rubella serosurveys at three Aravind Eye Hospitals in Tamil Nadu, India. Vijayalakshmi P, Anuradha R, Prakash K, Narendran K, Ravindran M, Prajna L, Brown D, Robertson SE. Bull World Health Organ; 2004 Apr 15; 82(4):259-64. PubMed ID: 15259254 [Abstract] [Full Text] [Related]
35. [Rubella epidemiology in Italy in years 1998-2004]. Giambi C, Rota MC, Bella A, Filia A, Gabutti G, Guido M, De Donno A, Ciofi degli Atti ML. Ann Ig; 2007 Apr 15; 19(2):93-102. PubMed ID: 17547214 [Abstract] [Full Text] [Related]
36. Rubella seroprevalence among Turkish adolescent girls living in Edirne, Turkey. Oner N, Vatansever U, Karasalihoglu S, Tatman Otkun M, Ekuklu G, Küçükugurluoglu Y. Turk J Pediatr; 2006 Apr 15; 48(4):288-93. PubMed ID: 17290561 [Abstract] [Full Text] [Related]
37. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan. Tseng HF, Chang CK, Tan HF, Yang SE, Chang HW. Vaccine; 2006 Jul 17; 24(29-30):5772-7. PubMed ID: 16759764 [Abstract] [Full Text] [Related]
38. Serum levels of rubella-specific antibodies in Swedish women following three decades of vaccination programmes. Kakoulidou M, Forsgren M, Lewensohn-Fuchs I, Johansen K. Vaccine; 2010 Jan 22; 28(4):1002-7. PubMed ID: 19925909 [Abstract] [Full Text] [Related]
39. Serologic status of women in an urban population in Brazil before and after rubella immunization campaign using routine screening data. Artimos de Oliveira S, Bastos Camacho LA, Uzeda Barreto MC, Coca Velarde LG, Siqueira MM. J Infect Dis; 2011 Sep 01; 204 Suppl 2():S664-8. PubMed ID: 21954264 [Abstract] [Full Text] [Related]
40. [Passive immunization against rubella: studies on the effectiveness of rubella-immunoglobulin after intranasal infection with rubella vaccination virus]. Neumann-Haefelin D, Neumann-Haefelin Ch, Petersen EE, Luthardt Th, Hass R. Dtsch Med Wochenschr; 1975 Jan 31; 100(5):177-81. PubMed ID: 1112230 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]